Cephalexin-induced acute generalized exanthematous pustulosis

Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associat...

Descripción completa

Detalles Bibliográficos
Autores principales: DaCunha, Matthew, Moore, Sarah, Kaplan, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207850/
https://www.ncbi.nlm.nih.gov/pubmed/30464809
http://dx.doi.org/10.4081/dr.2018.7686
_version_ 1783366599852425216
author DaCunha, Matthew
Moore, Sarah
Kaplan, David
author_facet DaCunha, Matthew
Moore, Sarah
Kaplan, David
author_sort DaCunha, Matthew
collection PubMed
description Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting.
format Online
Article
Text
id pubmed-6207850
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-62078502018-11-21 Cephalexin-induced acute generalized exanthematous pustulosis DaCunha, Matthew Moore, Sarah Kaplan, David Dermatol Reports Case Report Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting. PAGEPress Publications, Pavia, Italy 2018-10-01 /pmc/articles/PMC6207850/ /pubmed/30464809 http://dx.doi.org/10.4081/dr.2018.7686 Text en ©Copyright M. DaCunha et al., 2018 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
DaCunha, Matthew
Moore, Sarah
Kaplan, David
Cephalexin-induced acute generalized exanthematous pustulosis
title Cephalexin-induced acute generalized exanthematous pustulosis
title_full Cephalexin-induced acute generalized exanthematous pustulosis
title_fullStr Cephalexin-induced acute generalized exanthematous pustulosis
title_full_unstemmed Cephalexin-induced acute generalized exanthematous pustulosis
title_short Cephalexin-induced acute generalized exanthematous pustulosis
title_sort cephalexin-induced acute generalized exanthematous pustulosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207850/
https://www.ncbi.nlm.nih.gov/pubmed/30464809
http://dx.doi.org/10.4081/dr.2018.7686
work_keys_str_mv AT dacunhamatthew cephalexininducedacutegeneralizedexanthematouspustulosis
AT mooresarah cephalexininducedacutegeneralizedexanthematouspustulosis
AT kaplandavid cephalexininducedacutegeneralizedexanthematouspustulosis

Ejemplares similares